A monoclonal antibody -- a protein created in a lab which mimics the work of a natural antibody -- could be highly effective ...

Action News anchor Vanessa Vasconcelos sat down with Emergency Physician Doctor Rais Vohra to talk about viruses like the Flu ...

The monoclonal antibody nirsevimab, designed to mimic natural antibodies, significantly reduces severe RSV-related ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

HHS and the National Institutes of Health are developing a project that involves producing vaccines from chemically inactivated whole viruses with the goal of making “universal” vaccines that protect ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Tetanus-diphtheriaa-acellular pertussis–inactivated polio virus vaccination during pregnancy is safe and boosts ...

Neonatal antibiotic exposure was found to negatively impact vaccine responses, probably mediated by decreased Bifidobacterium ...

Flu activity continues to ebb nationwide, with rates of influenza-like illness (ILI) dropping further last week, but ...

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study.

Healthcare workers remain the most trusted sources of information (73%), while trust in the federal government to provide ...

program ensures greater accessibility for eligible children. This decision reflects the vaccine's ability to provide broader protection against meningococcal disease, a leading cause of bacterial ...